WHO ‘overstretched’ in response to increasing health emergencies

By Jennifer Rigby LONDON (Reuters) – A growing number of health emergencies around the world, from COVID-19 to cholera, have left the World Health Organization’s response “overstretched”, a senior advisor said on Tuesday. Speaking at the U.N. agency’s annual meeting, Professor Walid Ammar, chair of a committee reviewing the WHO’s emergency response, said funding and…

Read More

Judge tosses out some claims in Abbott baby formula litigation

By Jonathan Stempel (Reuters) – Abbott Laboratories persuaded a federal judge to dismiss some claims in nationwide litigation over recalled baby formula. In a decision on Monday, U.S. District Judge Matthew Kennelly in Chicago dismissed claims by parents pursuing only “economic loss” claims related to Similac and other formula that they said had a “substantial…

Read More

Diversified Healthcare Trust shareholder pushes for alternatives to OPI merger

By Svea Herbst-Bayliss NEW YORK (Reuters) – One of Diversified Healthcare Trust’s (DHC) largest shareholders is opposing the real estate investment trust’s merger with Office Properties Income Trust (OPI), saying the deal undervalues the REIT by 90% and there are better alternatives to an all-share deal. Flat Footed LLC, which holds a 7.4% stake, said…

Read More

Amgen settles patent lawsuit over biosimilar of J&J’s big-selling Stelara

By Blake Brittain (Reuters) -Johnson & Johnson has settled its lawsuit over Amgen Inc’s proposed biosimilar version of J&J’s top-selling treatment Stelara for psoriasis and other autoimmune conditions, according to a filing in Delaware federal court. Amgen said in a statement on Tuesday that the settlement terms are confidential, but it will allow the company…

Read More

Weight-loss drug pioneers aim to jump on Wegovy bandwagon

By Jennifer Rigby DUBLIN (Reuters) – Weight loss drug Wegovy has transformed the obesity market and pharmaceutical companies with existing treatments are hoping the resulting demand will boost demand for their older, less effective but cheaper, drugs. A weekly injection of Wegovy, which was launched in the U.S. in June 2021, leads to an average…

Read More

3M CEO must attend mediation in earplug litigation, judge rules

By Dietrich Knauth (Reuters) – A federal judge has ordered 3M Co CEO Michael Roman to attend mediation aimed at resolving nearly 260,000 lawsuits alleging that 3M military earplugs caused hearing loss, saying the negotiations have reached a “critical juncture.” U.S. District Judge Casey Rodgers, in whose Florida court the lawsuits have been consolidated, on…

Read More